» Articles » PMID: 38818369

Lung Cancer Patients with Anaplastic Lymphoma Kinase Rearrangement Lose Affiliation with Labor Market at Diagnosis

Abstract

The main purpose of the present study was to investigate the labor market affiliation of NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Nationwide retrospective study of all patients with NSCLC in Denmark diagnosed between 2012 and 2018. During the study period NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

References
1.
Marinelli D, Siringo M, Metro G, Ricciuti B, Gelibter A . Non-small-cell lung cancer: how to manage - and -rearranged disease. Drugs Context. 2022; 11. PMC: 9576009. DOI: 10.7573/dic.2022-3-1. View

2.
Pacheco J, Gao D, Smith D, Purcell T, Hancock M, Bunn P . Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer. J Thorac Oncol. 2019; 14(4):691-700. PMC: 7310567. DOI: 10.1016/j.jtho.2018.12.014. View

3.
Solomon B, Mok T, Kim D, Wu Y, Nakagawa K, Mekhail T . First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014; 371(23):2167-77. DOI: 10.1056/NEJMoa1408440. View

4.
Schmid S, Cheng S, Chotai S, Garcia M, Zhan L, Hueniken K . Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2022; 24(1):40-50. DOI: 10.1016/j.cllc.2022.09.007. View

5.
Planchard D, Popat S, Kerr K, Novello S, Smit E, Faivre-Finn C . Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(Suppl 4):iv192-iv237. DOI: 10.1093/annonc/mdy275. View